EXE vs. DNTL, SIA, WELL, DR, KDA, NLH, PHA, BHC, BLU, and TRIL
Should you be buying Extendicare stock or one of its competitors? The main competitors of Extendicare include dentalcorp (DNTL), Sienna Senior Living (SIA), WELL Health Technologies (WELL), Medical Facilities (DR), KDA Group (KDA), Nova Leap Health (NLH), Premier Health of America (PHA), Bausch Health Companies (BHC), BELLUS Health (BLU), and Trillium Therapeutics (TRIL). These companies are all part of the "medical" sector.
Extendicare vs. Its Competitors
Extendicare (TSE:EXE) and dentalcorp (TSE:DNTL) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, earnings, dividends, institutional ownership, profitability, analyst recommendations, risk and media sentiment.
17.3% of Extendicare shares are owned by institutional investors. Comparatively, 14.9% of dentalcorp shares are owned by institutional investors. 13.9% of Extendicare shares are owned by insiders. Comparatively, 0.2% of dentalcorp shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Extendicare has higher earnings, but lower revenue than dentalcorp. dentalcorp is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks.
Extendicare currently has a consensus price target of C$14.15, indicating a potential upside of 8.43%. dentalcorp has a consensus price target of C$12.82, indicating a potential upside of 56.36%. Given dentalcorp's stronger consensus rating and higher probable upside, analysts plainly believe dentalcorp is more favorable than Extendicare.
In the previous week, dentalcorp had 2 more articles in the media than Extendicare. MarketBeat recorded 2 mentions for dentalcorp and 0 mentions for Extendicare. Extendicare's average media sentiment score of 0.00 equaled dentalcorp'saverage media sentiment score.
Extendicare has a beta of 0.855319, indicating that its share price is 14% less volatile than the S&P 500. Comparatively, dentalcorp has a beta of 1.40413, indicating that its share price is 40% more volatile than the S&P 500.
Extendicare pays an annual dividend of C$0.49 per share and has a dividend yield of 3.7%. dentalcorp pays an annual dividend of C$0.05 per share and has a dividend yield of 0.6%. Extendicare pays out 50.6% of its earnings in the form of a dividend. dentalcorp pays out -21.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
Extendicare has a net margin of 4.48% compared to dentalcorp's net margin of -5.40%. Extendicare's return on equity of 64.13% beat dentalcorp's return on equity.
Summary
Extendicare beats dentalcorp on 10 of the 18 factors compared between the two stocks.
Get Extendicare News Delivered to You Automatically
Sign up to receive the latest news and ratings for EXE and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding EXE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Extendicare Competitors List
Related Companies and Tools
This page (TSE:EXE) was last updated on 9/5/2025 by MarketBeat.com Staff
